Clinical trial
Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small…
NCT00003696 · Commissie Voor Klinisch Toegepast Onderzoek, Other · Unknown status
Key facts
| NCT number | NCT00003696 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer |
| Official title | Phase III Study of Cyclophosphamide, Doxorubicin and Etoposide Compared to Carboplatin and Taxol in Patients With Extensive Disease Small Cell Lung Cancer |
| Lead sponsor | Commissie Voor Klinisch Toegepast Onderzoek, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, paclitaxel |
| Enrollment | 250 |
| Start date | Oct 1, 1998 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: